MetLife
MET · Life & Health Insurance
$98.82
4.6%Unum
UNM · Life & Health Insurance
$90.28
3.7%The short version
- MetLife is the larger business, with $77.1B of revenue in fiscal 2025 against $13.1B for Unum, about 5.9 times as much.
- MetLife grew revenue faster (8.6%, against 1.5%).
- Investors pay more for each dollar of Unum’s earnings: a P/E of 21.0x against 18.9x for MetLife.
| Latest fiscal year | MET · FY25 | UNM · FY25 |
|---|---|---|
| Size | ||
| Market cap | $63.9B | $14.4B |
| Revenue | $77.1B | $13.1B |
| Free cash flow | — | $555M |
| Net income | $3.4B | $739M |
| Growth | ||
| Revenue growth | 8.6% | 1.5% |
| 5-year growth | 2.6% | −0.1% |
| Share count change | −5.3% | −8.1% |
| Profitability | ||
| Gross margin | — | — |
| Operating margin | 8.0% | — |
| Net margin | 4.4% | 5.7% |
| FCF margin | — | 4.3% |
| Return on capital | — | 7.6% |
| Return on equity | — | 6.7% |
| Balance sheet | ||
| Net debt | −$10.8B | $593M |
| Net debt / EBITDA | −1.7x | 0.5x |
| Dividends and buybacks | $4.4B | $1.3B |
| Valuation & quality | ||
| P/E | 18.9x | 21.0x |
| Piotroski F-score | — | — |
FY16
MET $60.8B
UNM $11.0B
FY17
MET $62.3B
UNM $11.3B
FY18
MET $67.9B
UNM $11.6B
FY19
MET $69.6B
UNM $12.0B
FY20
MET $67.8B
UNM $13.2B
FY21
MET $68.7B
UNM $12.0B
FY22
MET $68.8B
UNM $12.0B
FY23
MET $66.9B
UNM $12.4B
FY24
MET $71.0B
UNM $12.9B
FY25
MET $77.1B
UNM $13.1B
MET
UNM
FY16
MET —
UNM —
FY17
MET —
UNM —
FY18
MET —
UNM —
FY19
MET —
UNM —
FY20
MET —
UNM —
FY21
MET —
UNM —
FY22
MET 8.7%
UNM —
FY23
MET 8.6%
UNM —
FY24
MET 8.5%
UNM —
FY25
MET 8.0%
UNM —
MET
UNM
FY16
MET —
UNM $1.0B
FY17
MET —
UNM $1.1B
FY18
MET —
UNM $1.4B
FY19
MET —
UNM $1.5B
FY20
MET —
UNM $350M
FY21
MET —
UNM $1.3B
FY22
MET —
UNM $1.3B
FY23
MET —
UNM $1.1B
FY24
MET —
UNM $1.4B
FY25
MET —
UNM $555M
MET
UNM
FY16
MET —
UNM 9.7%
FY17
MET —
UNM 9.9%
FY18
MET —
UNM 6.1%
FY19
MET —
UNM 11.1%
FY20
MET —
UNM 7.8%
FY21
MET —
UNM 10.9%
FY22
MET —
UNM 16.7%
FY23
MET —
UNM 13.1%
FY24
MET —
UNM 16.6%
FY25
MET —
UNM 7.6%
MET
UNM
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.